We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 8,986

California sick leave amendments offer (some) needed clarity for employers
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 30 2015

The California paid sick leave law provided a significant boon to employees not included under employers’ sick leave or paid time off policies, but


UK skilled worker cap hit for 1st time
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • United Kingdom
  • July 30 2015

Many US employers are exploring opportunities to expand globally. Due to the English-speaking special relationship between the US and the UK


The corporate practice prohibition in New York: what we can learn from the ADMI settlement
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 30 2015

One of the most frequently asked questions posed to healthcare lawyers is whether State X has a prohibition on the corporate practice of medicine


Check up or pay up: I-9 compliance fines hit CA company
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 29 2015

On July 8, 2015, the Office of the Chief Administrative Hearing Officer (OCAHO), issued a decision finding Hartmann Studios, Inc. “liable for 808


NLRB removes blanket exemption on mandatory disclosure for witness statements. What’s an employer to do?
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 28 2015

The NLRB recently reversed 37 years of precedent in deciding to adopt a new standard for a union's access to witness statements taken in


Emerging state biosimilar laws reference chart and five issues to watch
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 28 2015

As we've previously discussed, states have begun to actively regulate the substitution of interchangeable biosimilars before any FDA-approved


Does CPSC or FDA have jurisdiction over your consumer product?
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 28 2015

As our readers know, we write about legal developments that affect companies involved in manufacturing, importing, distributing, andor selling


Inglorious fraudsters: unlawfully sourced funds can taint EB-5 investments and result in forfeiture actions
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 28 2015

Last month, the United States District Court in the Eastern District of Pennsylvania (Philadelphia) ordered a default judgment against an interest in


Health care update - July 27 2015
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 27 2015

As part of a rare Senate Sunday session to consider a bill to replenish the highway trust fund for six years, Majority Leader Mitch McConnell


The Affordable Care Act’s reporting requirements for carriers and employers (part 2 of 24): yikes! The costs of failing to comply just doubled
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 27 2015

The Affordable Care Act (ACA) imposes information reporting rules on providers of minimum essential coverage, e.g., insurance carriers and